MedTrace Logo

Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy

NCT02461329 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-06-03

No results posted yet for this study

Summary

The purpose of the study is to determine whether volume therapy with a solution of gelatine has negative impact on coagulation, platelet function, renal function in comparison with crystaloid solution (Ringerfundin).

Conditions

  • Hemorrhage, Surgical
  • Hip Replacement, Total
  • Thrombocytopathy

Interventions

DRUG

Gelofusine® B. Braun

Volume therapy by Gelatine solution infusion via intravenous boluses to achieve hemodynamic targets

DRUG

Ringerfundin ® B. Braun

Volume therapy by Balanced Crystaloid solution solution infusion via intravenous boluses to achieve hemodynamic targets

Sponsors & Collaborators

  • IBA - Masaryk University Institute of biostatistics and analyses

    collaborator UNKNOWN

  • Kratochvil Milan, MD

    lead OTHER

Principal Investigators

  • Milan Kratochvil, MD · FN Brno

  • Milan Kratochvil, MD · FN Brno

  • Roman Gál, Prof, MD, Ph.D · Fn Brno

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-09-30
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02461329 on ClinicalTrials.gov